Le Lézard
Classified in: Health

Finding Safe Dental Anesthesia for Patients with Cardiovascular Disease


LAWRENCE, Kan., Nov. 13, 2019 /PRNewswire-PRWeb/ -- Anesthesia Progress ? As the global population of older adults (aged > 65 years) grows, the need to find pain management techniques that take systemic diseases into account increases. Currently, cardiovascular disease is one of the leading causes of morbidity and mortality in older adults. Finding a local anesthetic that does not affect blood pressure or heart rate during dental procedures is extremely important.

Researchers from the Tokyo Medical and Dental University and the Kyushu Dental University published a study in the current issue of Anesthesia Progress that compared the use of two different drug combinations in older adults during tooth extractions to determine local anesthetic effects on blood pressure and heart rate.

The researchers conducted a crossover study with 22 older adults, aged 65 to 86 years, in need of at least two maxillary tooth extractions. A combination of either lidocaine and adrenalin (L + AD) or prilocaine with felypressin (P + FP) was administered before tooth extraction. After anesthetic injection, blood pressure and heart rate were measured every 2.5 minutes for 20 minutes. Dental extractions in each subject were performed 5 days apart, in which L + AD was used for one extraction and P + FP was used for the other, so the researchers were able to examine the effect of both drug combinations on the same subject.

The researchers found an increase in both systolic and diastolic blood pressure in the P + FP group at all timepoints compared with the L + AD group. The systolic pressure did increase at the initial timepoint in the L + AD but then stayed constant throughout the procedure. However, when heart rate was measured, the researchers found an increase at all timepoints with L + AD and no real difference with P + FP.

The researchers conclude that in older adults who have blood pressure concerns, a combination of L + AD should be considered when performing dental procedures. In older adults with increased heart rates, the P + FP combination should be administered. The researchers suggest further studies are necessary to find more information on selecting safe local anesthetics for older adults with cardiovascular disease during dental procedures.

Full text of the article, "Cardiovascular Comparison of 2 Types of Local Anesthesia With Vasoconstrictor in Older Adults: A Crossover Study," Anesthesia Progress, Vol. 66, No. 3, 2019, is now available here: https://www.anesthesiaprogress.org/doi/full/10.2344/anpr-66-02-04.

About Anesthesia Progress
Anesthesia Progress is the official publication of the American Dental Society of Anesthesiology (ADSA). The quarterly journal is dedicated to providing a better understanding of the advances being made in the science of pain and anxiety control in dentistry. The journal invites submissions of review articles, reports on clinical techniques, case reports, and conference summaries. To learn more about the ADSA, visit: http://www.adsahome.org/.

 

SOURCE Anesthesia Progress


These press releases may also interest you

at 05:35
Atom Bioscience (Jiangsu Atom Bioscience and Pharmaceutical Co., Ltd.), a clinical stage biotechnology company developing new treatments for inflammatory and metabolic diseases, has begun enrolling patients in the US for in a Phase 2b/3 clinical...

at 05:30
Blockbuster growth in weight-loss drugs was the main driver of a 13.5% increase in spending on prescription medications in the U.S. in 2023, according to ASHP's (American Society of Health-System Pharmacists) report, National Trends in Prescription...

at 05:26
Renowned orthopedic surgeon Dr. Dror Paley, in partnership with Dr. León Mora and the Cora Group Excellence Center for Orthopedic Reconstructive and Limb Lengthening Surgery, is...

at 05:15
The Industrial Technology Research Institute (ITRI) triumphed at the recent Edison Awardstm in Fort Myers, Florida, securing recognition for four exceptional technological breakthroughs: the Novel Dual-Targeted Therapy for Glaucoma, Key Functional...

at 05:00
The Beta-Glucan Market is estimated at USD 542 million in 2024 and is projected to reach USD 800 million by 2029, at a CAGR of 8.1% from 2024 to 2029 according to a report published by MarketsandMarketstm. The growth of the beta-glucan market is...

at 05:00
Geekplus, the global leader in mobile robot and smart logistics solutions, has deployed the first Shelf-to-Person PopPick project in the Nordics for one of the biggest online pharmacy wholesalers in the region, Med24.dk. System Teknik partnered on...



News published on and distributed by: